PATENT CLAIM ANALYSIS

Application Number: 16368992
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "364000"]

Abstract:
The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.

Claim (Index 32):
The method of  claim 21 , wherein X is about 8 mg/kg to about 12 mg/kg.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.45652
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14221352', '16021419', '15643724', '15875296', '15345748']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8309289122353378
- 35 USC 102 Novelty (BERT): 0.6040243336993188
- Combined Prediction Score: 0.8082384543817359
- Mean Citation Score: 531.704782
- Max Citation Score: 537.7344
- Similarity Product: 462.12441030807497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test